Tele: 561.316.3330
Breaking Medical Device News

Saturday, October 16, 2021
HomeCLINICAL TRIALS, STUDIES, DATACIRCUL Ring Pulse Oximeter in Dark-Pigmented Individuals: Clinical Study Validates Efficacy and...

CIRCUL Ring Pulse Oximeter in Dark-Pigmented Individuals: Clinical Study Validates Efficacy and Reliability

February 26, 2021

CIRCUL Ring Pulse Oximeter clinical study validates efficacy and reliability in dark-pigmented participants, positioning as a superior continuous blood oxygen monitoring device for minority populations in the US and globally.

The reliability of pulse oximeters, noninvasive devices for assessing heart rate and oxygen-saturated hemoglobin, have recently been critiqued following an article published in the New England Journal of Medicine that suggested Black patients were at higher risk for hypoxemia and subsequent negative health impacts due to less accurate pulse oximeter measurements relative to those of white patients.

The CIRCUL™ Ring clinical validation study, conducted at the Tongde Hospital of Zhejiang Province, China, compared simultaneous measurements for the CIRCUL™ Ring and an arterial blood gas (ABG) test from 12 individuals (4 Black, ~33% of total enrollment). ABG test results are considered to be the most accurate method for measuring blood oxygenation levels but are more invasive due to the necessity of intravenous blood sampling. For Black individuals, 100 oxygen saturation measurements from the CIRCUL™ Ring showed excellent correlation with data obtained simultaneously from ABG testing for oxygen saturations ranging from 100% to 70%. The mean difference between CIRCUL™ and ABG values was only 1.06%.

The ongoing COVID pandemic highlights the importance of monitoring individuals’ blood oxygenation (SpO2) before, during, and after exposure or infection.

This was emphasized in a January 25, 2021 letter to the US Food and Drug Administration (FDA) by Senators Elizabeth Warren (D-Mass.), Cory Booker (D-N.J.), and Ron Wyden (D-Ore.) requesting a review of the accuracy of pulse oximeters across racially diverse patients and consumers.

The letter cites several studies suggesting pulse oximeters provide less accurate measurements for Black patients when compared to white patients, likely the result of racial bias in device calibration.

One such study found that low levels of blood oxygenation were up to three times as likely to go undetected in Black patients. The authors of that study further conclude their findings “highlight an ongoing need to understand and correct racial bias in pulse oximetry and other forms of medical technology.”

1 Oversight Letter to FDA dated January 25, 2021, “Senators Warren, Booker and Wyden Urge FDA to Address Concerns about Dangerous Pulse Oximeter Inaccuracies for Patients of Color”, https://www.warren.senate.gov/oversight/letters/senators-warren-booker-and-wyden-urge-fda-to-address-concerns-about-dangerous-pulse-oximeter-inaccuracies-for-patients-of-color

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy